Mitochondria Deploy Folate Defense Against Intracellular Parasites

This groundbreaking study reveals how mitochondria function as cellular defenders by competing with intracellular pathogens for essential nutrients. The research has significant implications for understanding both cellular immunity and mitochondrial biology in aging and disease.

Researchers infected human cells with Toxoplasma gondii, a common intracellular parasite, and discovered that infection triggers a sophisticated mitochondrial defense response. The key player is ATF4, a stress-response transcription factor that becomes activated when parasite proteins stress the mitochondria. ATF4 then drives increased production of enzymes involved in mitochondrial one-carbon metabolism, particularly MTHFD2 and SHMT2, which use folate to support DNA synthesis.

The critical finding is that this response increases mitochondrial DNA levels by approximately 30%, creating intense competition for folate between mitochondria and parasites. Since Toxoplasma requires folate-derived compounds to synthesize thymidine monophosphate (dTMP) for its own DNA replication, this mitochondrial folate sequestration effectively starves the parasite and limits its growth.

The researchers demonstrated this mechanism using multiple approaches, including CRISPR knockout cells lacking ATF4 or MTHFD2, which lost the ability to restrict parasite growth. Importantly, the response required parasite effector proteins rather than simple nutrient depletion, indicating this is an active defense rather than a passive consequence of infection.

These findings suggest that mitochondrial metabolism could be therapeutically targeted to enhance cellular defenses against intracellular pathogens. The research also provides new insights into how mitochondrial dysfunction might compromise immune responses, which could be particularly relevant for age-related immune decline where mitochondrial function deteriorates.